A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects. - Wikidata - awgldk - TriplyDB

A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects.

A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects.

http://www.wikidata.org/entity/Q43054768

about

Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progress Quercetin, Inflammation and Immunity Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials Low-grade inflammation, diet composition and health: current research evidence and its translation At the interface of antioxidant signalling and cellular function: Key polyphenol effects Molecular and physiological actions of quercetin: need for clinical trials to assess its benefits in human disease.Lipid lowering by hydroalcoholic extracts of Amaranthus caudatus L. induces regression of rabbits atherosclerotic lesions.The effect of quercetin supplementation on selected markers of inflammation and oxidative stress.A Mixed Flavonoid-Fish Oil Supplement Induces Immune-Enhancing and Anti-Inflammatory Transcriptomic Changes in Adult Obese and Overweight Women-A Randomized Controlled Trial Bioactive compounds with effects on inflammation markers in humans.Molecular mechanisms of the cardiovascular protective effects of polyphenols.Effect of flavonoids on circulating levels of TNF-α and IL-6 in humans: a systematic review and meta-analysis.Interference of flavonoids with fluorescent intracellular probes: methodological implications in the evaluation of the oxidative burst by flow cytometry.Flavonoids and immune function in human: a systematic review.Quercetin and Green Tea Extract Supplementation Downregulates Genes Related to Tissue Inflammatory Responses to a 12-Week High Fat-Diet in Mice.Mechanisms and therapeutic prospects of polyphenols as modulators of the aryl hydrocarbon receptor.A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C.Synergistic Anticancer Activities of Natural Substances in Human Hepatocellular Carcinoma.Inflammation and oxidative stress are lower in physically fit and active adults.Pelargonidin-3-O-glucoside and its metabolites have modest anti-inflammatory effects in human whole blood cultures.Review of the health effects of berries and their phytochemicals on the digestive and immune systems.Quercetin with vitamin C and niacin does not affect body mass or composition.Polyphenols and their effects on diabetes management: A review.

P2860

Q21284734-9BCEF1ED-AB53-460A-AB8D-9B1E63A09E79 Q26752987-E30D0979-6F9F-41C6-9D51-A7908E1AF186 Q26784434-73B6BF36-B3A7-445F-9474-39D17F71FD38 Q26801350-0BFD26E5-08EB-4802-B234-200BA5E7431E Q28071627-84A801E1-1A34-4362-860D-E25D7B42C8B3 Q34443935-E57F3003-34AA-4D7A-95D1-B50409C3217F Q35068227-654E2699-94A5-4BA9-B3B1-435CBC335F23 Q36938090-FA9B736B-9653-4867-BF21-8B29C7EED695 Q36941791-5DD9B450-80FE-4B95-B64B-97767523FAD0 Q37976087-7BB1D7EF-AC4F-4702-AAE2-709E0A49ADD6 Q38039247-95960CEA-DD55-493A-969E-D8B168032773 Q38087565-87760C6A-F314-43C7-8E0B-98A094B6C3F6 Q38216941-9B972349-4875-4F3C-AB69-409C8930A83E Q38219164-5DBB60B8-64BE-42AC-886A-F3DB49B94EA9 Q38654917-F9C936E0-BC4C-4681-B9D3-C1111A598ED8 Q39176010-C85B88D2-7C38-484D-AA9B-4C3E8F1570B9 Q40888934-17C32604-3BCC-4F4D-A7E7-EF490B650AA9 Q42343450-3D51DB8E-E279-4B65-95AD-101E08D4E101 Q45200827-3B582E42-B2FB-4587-8E84-BAB9AF048DC6 Q47164252-68695271-E2AD-40E8-8FCC-9200DCC65263 Q47395754-FD2FB00C-0D43-488A-BCC7-B9F7E29D69E7 Q51463017-7B79C61C-930A-47B5-84B4-0D23EF289D38 Q55285286-28D1817E-F21D-469F-ABE7-4CB22834993C

P2860

A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects.

http://www.wikidata.org/entity/Q43054768

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

A 12-week supplementation with ...... osis in female human subjects.

@en

A 12-week supplementation with ...... osis in female human subjects.

@nl

type

label

A 12-week supplementation with ...... osis in female human subjects.

@en

A 12-week supplementation with ...... osis in female human subjects.

@nl

prefLabel

A 12-week supplementation with ...... osis in female human subjects.

@en

A 12-week supplementation with ...... osis in female human subjects.

@nl

P1433

Q43054768-FDE98A92-8DE1-43AE-B0FC-128D383A0A0F

P1476

Q43054768-5E6CFA23-440E-4634-8890-34E73484D0C9

P2093

Q43054768-6B568C0B-E09B-4CF9-AC55-0F780C662C7C

Q43054768-8C7C24CF-BABE-41B4-9563-526197742A07

Q43054768-D5B8CE6E-C259-4069-8FCF-9594EB6BDB08

Q43054768-EB1289A6-522E-42C1-857B-1AC11B49F4B7

Q43054768-F1CDAD65-2A43-41C8-9267-457FAF8E8189

P2860

Q43054768-00C6F2FA-F1B1-4A60-801B-9AAFBCE2CE00

Q43054768-040D9282-E01D-4AB8-85FC-DC4BD17225D0

Q43054768-0EFBF5FC-FE09-4B67-A6C5-1419D6056C0A

Q43054768-178D4A9F-67C1-4015-B500-A85238D7B0AD

Q43054768-180AA61E-B2D2-40E3-A5E6-B4965C6D004F

Q43054768-28FF2E8D-E8BA-4669-80C0-6087265A295E

Q43054768-2BD429F6-A55D-43EC-9A66-0DB2B0D6C747

Q43054768-3A90822D-663B-4808-B648-58C097F6299E

Q43054768-3E679F68-8CDC-4C4C-9F17-5E4989413122

Q43054768-56ACF86C-FEE3-4B7C-938C-00F4D18C1D18

P304

Q43054768-08450EFF-329D-47FB-9787-68935D99AF0C

P31

Q43054768-51F641DE-23B0-4DCC-9802-1B7905D187E5

P356

Q43054768-781A778E-3156-457D-966E-E432EDD96A90

P433

Q43054768-0EE1B693-C4DA-4EEE-B0BE-F28620A17D1A

P478

Q43054768-C2E71371-34AA-4B4E-A4E6-00FB101C0AF2

P577

Q43054768-1550D8C2-7D29-44D8-9DD4-30F588584C0B

P5875

Q43054768-89776298-DDE7-4ADC-BB76-3CB2328EC7DE

P698

Q43054768-AE22A2F4-F5AD-47D8-B317-2A2CBE2A737B

P921

Q43054768-8294C937-72A0-4188-A673-E38DA0A1ACFF

Q43054768-BC2BD3DA-21A4-4A3E-8FDF-0253416B58B7

P356

S000711451000156X

P1433

British Journal of Nutrition

P1476

A 12-week supplementation with ...... osis in female human subjects.

@en

P2093

David C Nieman

http://www.w3.org/2001/XMLSchema#string

Dru A Henson

http://www.w3.org/2001/XMLSchema#string

Fuxia Jin

http://www.w3.org/2001/XMLSchema#string

Melanie D Austin

http://www.w3.org/2001/XMLSchema#string

Serena A Heinz

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review

A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties.

Measurement of cytokines in sweat patches and plasma in healthy women: validation in a controlled study.

Evaluation of the potential in vivo genotoxicity of quercetin.

Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells.

Dietary flavonoids and cancer risk: evidence from human population studies.

The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system.

The biology of human natural killer-cell subsets.

Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance.

Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.

P304

849-857

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S000711451000156X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44628862

http://www.w3.org/2001/XMLSchema#string

P698

20500927

http://www.w3.org/2001/XMLSchema#string

P921

human subject research